๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Trimetrexate in advanced carcinoma of the esophagus

โœ Scribed by Albert S. Alberts; Geoffrey Falkson; Mamud Badat; Aletta P. S. Terblanche; Eugen U. Schmid

Publisher
Springer US
Year
1988
Tongue
English
Weight
207 KB
Volume
6
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Trimetrexate in advanced renal cell carc
Trimetrexate in advanced renal cell carcinoma
โœ Robert S. Witte; Paul Elson; George T. Bryan; Donald L. Trump ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer US ๐ŸŒ English โš– 313 KB
An eastern cooperative oncology group ph
An eastern cooperative oncology group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma
โœ Robert S. Witte; Paul Elson; Janardan Khandakar; Donald L. Trump ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 359 KB ๐Ÿ‘ 2 views

## Background. Trimetrexate is an antifol that differs from methotrexate in ways that may be clinically important. Because methotrexate has activity in advanced bladder cancer, this trial was initiated.

Management for patients with advanced T4
Management for patients with advanced T4 epidermoid carcinoma of the esophagus
โœ Wang, Liang-Shun; Chi, Kwan-Hwa; Hu, Maw-Hwa; Fahn, Huei-Jyh; Huang, Min-Hsiung ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 812 KB

Available data concerning the treatment of patients with advanced T4 esophageal carcinoma are limited. A consecutive series of 42 patients with advanced T4M0 epidermoid carcinoma of the esophagus were studied from June 1987 to July 1992. The aim of this study was to evaluate the efficacy of various